EU Approves Franco-German Aventis Merger With Conditions

Jan. 13, 2005
BRUSSELS: The European Union commission announced Aug. 10 its conditional approval for the proposed merger of pharmaceuticals companies Rhone-Poulenc of France and Hoechst of Germany to create Aventis, one of the largest life-sciences groups in the ...
BRUSSELS: The European Union commission announced Aug. 10 its conditional approval for the proposed merger of pharmaceuticals companies Rhone-Poulenc of France and Hoechst of Germany to create Aventis, one of the largest life-sciences groups in the world. In a written statement, the commission said that the companies made commitments that will eliminate any competition concerns the deal may have posed. According to the commission, Aventis will become the second largest pharmaceuticals company in terms of worldwide turnover, closely followed by Glaxo Wellcome, AstraZeneca, Pfizer, Bristol-Myers Squibb, and Novartis. In the plant protection sector Aventis will be the world leader in terms of turnover, ahead of Novartis by a narrow margin, the Commission said.

Popular Sponsored Recommendations

Top 3 Ways AI is Transforming Manufacturing Operations

Feb. 17, 2024
Unlock the power of Industry 4.0 with AI and IoT. Explore how real-time data and automation are reshaping manufacturing, driving efficiency and quality to new heights. Dive into...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Shop Floor Optimization Solves Manufacturers’ Labor Challenges

Dec. 27, 2023
Read this FAQ to learn how mid-market manufacturers can use technology to optimize their shop floors and make better use of their available labor forces.

S&OP Optimization: Data-driven Strategies to Achieve Sustainable Profitability

Feb. 6, 2024
Through collaborative S&OP, manufacturers can balance demand and supply effectively, optimize resources, and capitalize on emerging market opportunities. Learn how to maximize...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!